Cancer

Article	Citations
Indeterminate pulmonary nodules in non‐rhabdomyosarcoma soft tissue sarcoma: A study of the European paediatric Soft Tissue Sarcoma Study Group	1484
Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors	309
Issue Information	221
A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center	175
Modeled residual current cancer risk after clinical investigation of a positive multicancer early detection test result	153
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	145
Measuring the impact of a catchment area surveillance tool on cancer center adopters	132
Impact of obesity on outcome in children diagnosed with cancer in Canada: A report from Cancer in Young People in Canada	118
	112
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	110
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors	104
Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)	104
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532	97
Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?	93
Association of statin use with clinical outcomes in patients with triple‐negative breast cancer	88
Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019	88
Individual‐ and neighborhood‐level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California	85
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study	72
Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery	70
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan	68
Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model	66
Risk of suicide among individuals with a history of childhood cancer	55
Oncology patients' perception of physicians who use an integrated electronic health record (EHR) during clinic visits: PRIME‐EHR double‐blind, randomized controlled trial	54
Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”	53
Intersecting identities and cancer screening	52

Issue Information	51
More social determinants lead to more cancer death: A tragic dose response	49
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study	49
Lower risk of depression after smoking cessation and alcohol abstinence in patients with gastric cancer who underwent gastrectomy: A population‐based, nationwide cohort study	49
Pediatric inflammatory bowel disease increases cancer risk	49
Issue Information	49
New standard of care for multiple myeloma?	48
Altering the microbiome for immunotherapy‐resistant urological tumors—An intriguing but still early concept	48
Issue Information	47
MRI‐guided radiotherapy results in fewer toxicities for localized prostate cancer	47
First person profile: Mary‐Ellen Taplin, MD	47
Talazoparib for newly diagnosed prostate cancer associated with significant risk reduction of disease progression	46
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?	46
Frequency and clinical associations of common mental disorders in adults with high‐grade glioma—A multicenter study	45
Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials	45
Withdrawal: “Assessment of prognostic understanding, perceived goals of care, and quality of life in hospitalized patients with leukemia or multiple myeloma” Olivia S. Allen, Nina Kim, Jose Morillo, C	45
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy	42
Federal Cervical Cancer Collaborative: Improving cervical cancer prevention through vaccination, screening, and management in safety‐net settings of care	42
Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion	42
Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta‐analysis	42
Agreement of medical record abstraction and self‐report of breast cancer treatment with an extended recall window	42
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single‐arm, phase 2 trial	42
Gender equity in oncology: Progress, challenges, and the path forward in urologic oncology and oncologic specialties	41
Cost and activity analysis for a citywide patient navigation intervention to engage underserved patients in breast cancer treatment: Findings from the Translating Research Into Practice study	41
The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer (CISTO) study: Lessons learned about management and patient enrollment in a large, pragmatic, patient‐centere	41
Erratum to “Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study”	41
Prevalence of carotid ultrasound screening in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study	40
Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare	40
Association between visceral adiposity index and cancer risk in the UK Biobank cohort	40
Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality	39
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma	39
The impact of a small‐group mammography video discussion on promoting screening uptake among nonadherent Chinese American immigrant women: A randomized controlled trial	39
Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care	38
Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuva	38
New first‐line treatment improves progression‐free survival for select men with bone mCRPC	37
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases	37
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer	36
	36
First person profile: Richard Pazdur, MD	36
Issue Information	36
Racism and health among cancer survivors	36
Issue Information	36
Cost effectiveness of treatment strategies for high risk prostate cancer	35
Evaluation of headache in patients with cancer	35
von Hippel–Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement	34
Temporal changes in the probability of live birth among female survivors of childhood cancer: A population‐based Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study in five nordic countrie	34
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer	33
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study	33
An ounce of prevention: Medicaid's role in reducing the burden of cancer in men with HIV	33
Making progress against rare cancers: A case study on neuroendocrine tumors	33

Industry engagement: Accelerating discovery, application, and adoption through industry partnerships	33
A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study	32
Fine‐tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic‐phase chronic myeloid leukemia: The choice of the right TKI for the right patient	32
Challenges in clinical trials for high‐risk but curable prostate cancer	32
Person‐centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity	32
Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials	31
Issue Information	31
Circulating tumor DNA in head and neck cancer: Early successes and future promise	31
Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis	31
Durable efficacy with fixed‐duration BTKi and venetoclax for CLL	31
Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls	31
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome	30
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)	30
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation	29
What enhanced recovery means for patients with cancer undergoing surgery	29
The National Cancer Act of 1971: A seminal milestone in the fight against cancer	29
Issue Information	29
Adolescent and young adult cancer survivors are at increased risk for a second cancer	29
Heart failure linked with an increased risk of cancer	29
What if the age at which a woman started regular mammographic screening depended on her risk, not age?	29
Frail young adult cancer survivors experience poor health‐related quality of life	29
Oncologist affects integrative cancer care by writing songs with patients	28
Associations between racial categories and outcomes suggest structural causes, not genetic advantages	28
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	28
	28
Potential of circulating tumor DNA to refine immunotherapy	28
Attack of the clones: Unveiling subclonal/heterogenous mismatch repair/microsatellite instability status in endometrial cancer	28
	28
SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma	28
	28
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality	27
In pursuit of equity in cancer care: Moving beyond the Affordable Care Act	27
The important role of nighttime compression in breast cancer–related lymphedema treatment	27
Association of the m6A reader IGF2BP3 with tumor progression and brain‐specific metastasis in breast cancer	27
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenou	27
Reply to Air pollution was high centuries before industrial revolutions and may have been responsible for cancer rates in medieval Britain	26
Improving colorectal cancer screening by providing options	26
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation	26
Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population	26
Gut microbiome linked to aggressive prostate cancer	26
Pathfinders in oncology from the time the causal relation between tobacco use and lung cancer was established to publication of the first Cancer Staging Manual by the American Joint Committee on Cance	26
Volume standards and outcomes measurement—Complementary strategies to improve surgical quality	26
Issue Information	25
Higher severity and risk of in‐hospital mortality for COVID‐19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data	25
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort stu	25
The effects of curative‐intent cancer therapy on employment, work ability, and work limitations	25
Updated American Cancer Society lung cancer screening guidelines	25
FDA approves new combined treatment for advanced prostate cancer	25
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall	25
ASCO releases equity, diversity, and inclusion action plan	25
Anticancer therapies increase thromboembolic risk in hospitalized patients with cancer and COVID‐19	24
Sex‐based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report	24
Health insurance literacy among patients receiving outpatient cancer treatment	24
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	24
Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update	24
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma	24
Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VIS	24
Reply to “Metformin as a booster or obstacle of immunotherapy in patients with non–small cell lung cancer and diabetes mellitus”	24
Routine estradiol testing recommended for women at high risk of breast cancer	24
Transplantation for myeloid neoplasms with antecedent solid tumor	24
Association between prediagnostic prostate‐specific antigen and prostate cancer probability in Black and non‐Hispanic White men	24
A nomogram for predicting axillary node pathologic complete response—A necessary component of the path toward true axillary de‐escalation but needs a clear definition of the research question and a ro	24
	23
	23
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer	23
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade	23
An invisible population: Late‐stage cancer diagnosis for people with intellectual or developmental disability	23
Implementation, enrollment, and engagement in an opt‐out telehealth pharmacist‐assisted tobacco treatment program for patients seen in oncology outpatient clinics	23
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer	23
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features	22
Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population‐based cohort study in Taiwan	22
Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status	22
The importance of the person/patient/survivor's lived experience across the cancer control continuum	22
New test for detecting cervical adenocarcinoma	22
Breast screening participation and degree of spread of invasive breast cancer at diagnosis in mental health service users: A population linkage study	22
Thank You to Reviewers 2023	22
Evaluating the sustainability of patient navigation programs in oncology by length of existence, funding, and payment model participation	22
Critical insights into the evolving drug‐approval process in China	22
Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer	22
Children and adolescents with hematologic cancers deserve better end‐of‐life care	22

Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system	22
Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer	21
Breast arterial calcification is a risk factor for cardiovascular disease	21
	21
Training oncology care providers in the assessment and treatment of tobacco use and dependence	21
The economics of advanced and unresectable hepatocellular carcinoma	21
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	21
Brain–computer interface relieves chronic chemotherapy‐induced peripheral neuropathy: A randomized, double‐blind, placebo‐controlled trial	21
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?	21
Issue Information	20
Patients with glioblastoma: A tale of health care access and genetic ancestry	20
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients	20
Role of primary care in opioid prescribing for older head and neck cancer survivors	20
Issue Information	20
Myeloma, melphalan, and the taste of transplantation	20
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people	20
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls	20
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt	20
Reply to “Micro‐ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI‐RADS 3 lesions”	20
Top advances of the year: Pediatric oncology	20
Yale study finds Black patients are more likely to experience uterine cancer testing delays	20
	20
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	20
Antiprogrammed death ligand 1 therapy failed to reduce the risk of developing brain metastases in patients with extensive‐stage small cell lung cancer: A retrospective analysis	19
Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies	19
Issue Information	19
Issue Information	19
Annual report to the nation on the status of cancer	19
Issue Information	19
Top advances of the year: Myeloproliferative neoplasms	19
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	19
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana	19
Race‐inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?	19
Immunotherapy for metastatic non–small cell lung cancer: Is it really a no‐brainer?	18
Erratum to “Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study”	18
Caregiver burden among diverse caregivers	18
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data	18
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study	18
Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancer	18
The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival	18
Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies	18
	18
Female breast cancer most commonly diagnosed cancer globally	18
Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database	18
Falls prechemotherapy and toxicity‐related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial	18
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	18
Management recommendations for pancreatic manifestations of von Hippel–Lindau disease	18
Rare disease research powered by empowered patients: solving the zebra puzzle through social media	18
Atezolizumab plus bevacizumab versus nivolumab as first‐line treatment for advanced or unresectable hepatocellular carcinoma: A cost‐effectiveness analysis	18
Establishing a health profession: What oncology patient navigators can learn from the National Association of Community Health Workers	18
	17
Preclinical evaluation and phase 1 study of the PI3Kα/δ inhibitor TQ‐B3525 in Chinese patients with advanced cancers	17
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas	17
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial	17
Impact of smoking status on engagement in remote symptom monitoring after oncologic surgery: Implications for symptom management and readmission rates	17
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia	17
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard‐of‐care?	17
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study	17
Dispositional hope as a potential outcome parameter among patients with advanced malignancy: An analysis of the ENABLE database	17
Certain cancer types show global variation in mortality rates	17
Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B‐cell lymphoma	17
Issue Information	17
Evaluating the impact of multicancer early detection testing on health and economic outcomes: Toward a decision modeling strategy	17
Top advances of the year: Pancreatic cancer	17
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors	17
Assessing trends in breast care surveillance metrics after implementing surgeon‐specific tracking and performance reporting in a large, integrated cancer network	17
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design	17
Exemptions to state laws regulating opioid prescribing for patients with cancer‐related pain: A summary	16
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	16
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network	16
Economic distress, financial toxicity, and medical cost‐coping in young adult cancer survivors during the COVID‐19 pandemic: Findings from an online sample	16
Chemotherapy with the use of next‐generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults	16
	16
Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1	16
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer	16
Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis	16
MatchMiner open‐source platform matches patients with cancer to precision medicine trials	16
Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study	16
Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry	16
Mental health screening and diagnosis in cancer patients: Impact on mortality and suggestion of racial bias	16
Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma	16
Clinical and genetic risk factors for radiation‐associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort	16
Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: Implications for breast cancer–related adverse health events	16
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status	16
The enigma of race and prostate cancer	16
Issue Information	16
Advancing immunotherapy in small cell lung cancer	16
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders	16
Association of physical exercise and a healthy gut microbiome in colorectal cancer	15
Single‐photon emission computed tomography‐defined active bone marrow‐sparing volumetric‐modulated arc therapy reduces the incidence of acute hematologic toxicity in locally advanced cervical cancer p	15
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers	15
Entecavir combined with interferon‐α Is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B	15
Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing	15
Optimal timing of radiotherapy after radical prostatectomy points to salvage radiotherapy for PSA failure	15
Issue Information	15